Hypertension (high blood pressure) decisions — 2025

The Board denied an effective date prior to August 10, 2022 for the grant of service connection for hypertension.

The Veteran's service-connected disabilities, including PTSD and TBI with intermittent dizziness, migraine headaches, tinnitus, and hypertension, have rendered him unable to secure or follow a substantially gainful occupation.

The Board granted service connection for hypertension and sleep apnea, but remanded the claims for loss of smell and taste.

The Board granted a separate disability rating of 40 percent for residuals of traumatic brain injury (TBI) and a separate evaluation of 50 percent for an acquired psychiatric disorder, characterized as generalized anxiety disorder with unspecified depressive disorder.

The Board denied the Veteran's claim for an initial compensable rating for hypertension, finding that there was no evidence of diastolic pressure predominantly 100 or more or systolic pressure predominantly 160 or more.

The Board granted service connection for hypertension as due to exposure to herbicide agents on a direct basis and denied service connection for left jaw cancer, as due to exposure to herbicide agents.

The Board denied an earlier effective date for the award of service connection for tinea pedis with onychomycosis and remanded issues related to a higher rating, special monthly compensation, and TDIU.

The Board remands the claims for a new VA examination to address the full range of complaints associated with the Veteran's service-connected hypertension and its impact on employability.

The appeal for service connection for multiple conditions has been withdrawn by the Veteran.

The appeal was granted for service connection of an acquired psychiatric disorder, and the claims for high blood pressure, insomnia, left knee, and right knee disorders were remanded.

The Board denied service connection for multiple conditions, including hypertension, cervical spine condition, shoulder conditions, chronic fatigue syndrome, gastrointestinal issues, psychiatric disorder, and coccidioidomycosis.

The Board dismissed the claims for service connection for bilateral pes planus and migraines as they were fully resolved in a prior rating decision. The claim for service connection for hypertension was remanded for further development.

The Board denied the Veteran's claim for an initial compensable rating for hypertension and remanded claims for service connection for atopic dermatitis, breast cancer, and depression as secondary to breast cancer.

The Veteran was granted a 70 percent evaluation for TBI with BPPV and memory loss effective from April 9, 2021, to June 22, 2021, and Chapter 35 DEA benefits for the same period. The grant of service connection for obstructive sleep apnea was denied an earlier effective date.

The Board granted service connection for obstructive sleep apnea (OSA), but dismissed the appeals for posttraumatic stress disorder (PTSD) and hypertension.

The Board granted an earlier effective date of October 27, 2021, for the award of service connection for hypertension based on direct service connection and denied a higher disability rating.

The Board granted service connection for hypertension and ED, denied service connection for obesity and bilateral hearing loss, and granted ratings of 20 percent or less for various lower extremity radiculopathies and right hand strains.

The Board denied the Veteran's claims for service connection for pulmonary hypertension and a total disability rating based on individual unemployability (TDIU) due to pulmonary hypertension.

The Board denied service connection for hypertension and kidney cancer as there was no evidence of in-service exposure to herbicide agents, and the conditions were not shown to be related to the Veteran's military service.

The Board remands the issue of entitlement to service connection for hypertension due to an inadequate VA examination and potential outstanding private treatment records.